<DOC>
	<DOCNO>NCT01798498</DOCNO>
	<brief_summary>The aim clinical trial evaluate efficacy safety Princess® VOLUME correction nasolabial fold .</brief_summary>
	<brief_title>Study Evaluation Efficacy Safety Dermal Filler Princess® VOLUME Nasolabial Folds</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Major Male female subject 30 year 65 year Wrinkle score least 2 accord Modified Fitzpatrick Wrinkle Scale ( MFWS ) Major For female : pregnancy , lactating , plan pregnancy unwilling use contraceptives History allergic reaction hyaluronic acid product Facial surgery implantation dermal filler nasolabial region within last 24 month Skin nasolabial region affect cosmetic treatment ( e.g . laser therapy within last 12 month , chemical peeling within last 3 month , dermabrasion within last 12 month , botulinum toxin within last 12 month ) Connective tissue diseases Diabetes mellitus uncontrolled systemic disease Known human immune deficiency viruspositive individual Presence silicone implant another nonabsorbable substance ( permanent filler ) area product application Cutaneous lesion evaluate area Tendency keloid formation and/or hypertrophic scar Autoimmune disease History allergies cosmetic filling product recurrent herpes simplex History immune system degradation</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>